[Pharmacological interference of glibornuride with sulfaphenazole, phenylbutazone, and phenprocoumon in man].
D000328:Adult; D001593:Benzyl Compounds / Q000494:pharmacology; D001786:Blood Glucose; D001892:Camphanes / Q000494:pharmacology; D003374:Coumarins / Q000494:pharmacology*; D003920:Diabetes Mellitus; D004347:Drug Interactions; D006207:Half-Life; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000494:pharmacology*; D013426:Sulfaphenazole / Q000494:pharmacology*; D013453:Sulfonylurea Compounds / Q000494:pharmacology* / Q000652:urine; D013460:Sulfur Isotopes
D001593:Benzyl Compounds; D001786:Blood Glucose; D001892:Camphanes; D003374:Coumarins; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D013460:Sulfur Isotopes; D013426:Sulfaphenazole; D010653:Phenylbutazone
Zur pharmakologischen Interferenz von Glibornurid mit Sulfaphenazol, Phenylbutazon und Phenprocoumon beim Menschen.